Estrella Immunopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 3.98 M | $4.13 M | -3.02% | 9.25% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 416.85 K | $433.53 K | 8.99% | 0.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 141.32 K | $146.97 K | -10.26% | 0.33% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 64.92 K | $67.52 K | 0.00% | 0.15% |
| BLACKROCK, INC. | 08/07/2026 | 52.03 K | $54.11 K | 30.44% | 0.12% |
| STATE STREET CORP | 09/22/2026 | 43.25 K | $44.98 K | 0.00% | 0.10% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 39.10 K | $40.66 K | -37.73% | 0.09% |
| NORTHERN TRUST CORP | 08/13/2026 | 34.86 K | $36.26 K | 77.64% | 0.08% |
| US BANCORP \DE\ | 08/12/2026 | 20.00 K | $20.80 K | 18.32% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 3.31 K | $3.44 K | -31.92% | 0.01% |
| UBS GROUP AG | 08/13/2026 | 1.72 K | $1.79 K | -88.59% | 0.00% |
| TORONTO DOMINION BANK | 08/14/2026 | 1.09 K | $1.13 K | 0.00% | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 08/10/2026 | 468 | $487 | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 126 | $131 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 2 | $2 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Estrella Immunopharma Inc institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Estrella Immunopharma Inc. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 3.98 M
VANGUARD CAPITAL MANAGEMENT LLC: 416,852
GEODE CAPITAL MANAGEMENT, LLC: 141,321
VANGUARD FIDUCIARY TRUST CO: 64,921
BlackRock, Inc.: 52,033
STATE STREET CORP: 43,252
11.15% of Estrella Immunopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 5.30 M shares in the last 24 months. This purchase volume represents approximately $5.94 M in transactions.